XML 31 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings Per Share
6 Months Ended
Jun. 30, 2020
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
Note 12 – Earnings Per Share
The following table summarizes earnings per share calculations
 
for the three and six months ended June 30, 2020 and 2019:
Three Months Ended
 
Six Months Ended
June 30,
June 30,
2020
2019
2020
2019
Basic (loss) earnings per common share
 
 
 
Net (loss) income attributable to Quaker Chemical Corporation
$
 
(7,735)
$
15,591
$
 
(36,116)
$
29,435
Less: loss (income) allocated to participating securities
 
37
 
(34)
 
146
 
(81)
Net (loss) income available to common shareholders
$
 
(7,698)
$
15,557
$
 
(35,970)
$
29,354
Basic weighted average common shares outstanding
17,697,496
13,304,248
17,685,010
13,297,953
Basic (loss) earnings per common share
$
(0.43)
$
1.17
$
(2.03)
$
2.21
Diluted (loss) earnings per common share
Net (loss) income attributable to Quaker Chemical Corporation
$
(7,735)
$
15,591
$
 
(36,116)
$
29,435
Less: loss (income) allocated to participating securities
37
 
(34)
 
146
 
(81)
Net (loss) income available to common shareholders
$
(7,698)
$
15,557
$
(35,970)
$
29,354
Basic weighted average common shares outstanding
17,697,496
13,304,248
17,685,010
13,297,953
Effect of dilutive securities
48,007
47,362
Diluted weighted average common shares outstanding
17,697,496
13,352,255
17,685,010
13,345,315
Diluted (loss) earnings per common share
$
(0.43)
$
1.17
$
(2.03)
$
2.20
During the third quarter of 2019, the Company issued
 
approximately
4.3
 
million shares of common stock, comprising
24.5
% of
the common stock of the Company immediately after
 
the closing, as a component of the consideration transferred in the Combination.
Certain stock options and restricted stock units are not included
 
in the diluted (loss) earnings per share calculation because the effect
would have been anti-dilutive.
 
All of the Company’s potentially
 
dilutive shares for the three and six months ended June
 
30, 2020 are
anti-dilutive and not included in the dilutive (loss) earnings
 
per share calculation because of the Company’s
 
net loss for the periods.
 
Comparatively,
 
there were
no
 
anti-dilutive shares for the three and six months ended
 
June 30, 2019.